Educational activities of nurses in patients after myocardial infarction – a review
Authors:
J. Doležel; D. Jarošová
Authors place of work:
Ústav ošetřovatelství a porodní asistence, LF OU, Ostrava
Published in the journal:
Kardiol Rev Int Med 2017, 19(3): 205-208
Summary
Introduction:
In recent years the basis of coronary heart disease prevention shifts from medical treatment to preventive non-pharmacological interventions. Education of patients after myocardial infarction leads to increased physical activity and healthier diet and consequently to a lower occurrence of stenocardia during daily activities.
Objective:
The aim of the survey study is to analyse the existing studies dealing with educational activities of nurses in patients after myocardial infarction.
Methods:
The search for studies was done in bibliographic databases by keyword and on the basis of input and exclusionary criteria.
Results:
The results of the review were focused on the evaluation of organizational forms of education, methods of education, used material didactic resources, the objectives of education, the results of the education, the length of education, educational history, content of education, subsequent checks in the wake of educational activities and monitored clinical outcomes.
Conclusions:
The findings should serve as a basis for the creation of educational materials for patients after myocardial infarction. The analysis of individual studies showed that such materials cannot rely on one source only, but specific information should be used from selected studies.
Keywords:
myocardial infarction – secondary prevention – education – lifestyle modification – nursing care
Zdroje
1. Cífková R, Bruthans J, Adámková V. Prevalence základních kardiovaskulárních rizikových faktorů v české populaci v letech 2006– 2009. Studie Czech post-MONICA. Cor Vasa 2011; 53(2): 220– 9.
2. Kotseva K, Wood D, De Backer G et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16(2): 121– 137. doi: 10.1097/ HJR.0b013e3283294b1d.
3. Piepoli MF, Hoes AW, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37(29): 2315– 2381. doi: 10.1093/ eurheartj/ ehw106.
4. Rombhane HB et al. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization 2007.
5. Grant J et al. SIGN vol. 97. Risk estimation and the prevention of cardiovascular disease. Edinburgh: Scottish Intercollegiate Guidelines Network 2007. Available at: http:/ / www.sign.ac.uk.
6. Jessani S, Watson T, Cappuccio FP et al. Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) Guidelines. J Human Hypertens 2006; 20(9): 641– 645. doi: 10.1136/ hrt.2005.079988.
7. Newby D et al. SIGN vol. 148. Acute Coronary Syndrome: a National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network 2016. Available from: http:/ / www.sign.ac.uk.
8. Capatano AL, Graham I, De Backer G et al. ESC/ EAS Guidelines for the Management of Dyslipidemias. Eur Heart J 2016; 37(39): 2999– 3058. doi: 10.1093/ eurheartj/ ehw272.
9. Stone NJ, Robinson JG, Lichtenstein AH et al. ACC/ AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 2014; 63(25): 2889– 2934. 10.1016/ j.jacc.2013.11.002.
10. Eckel RH, Jakicic JM, Ard JD et al. 2013 AHA/ ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation 2014; 129 (25 Suppl 2): S76– S99. doi: 10.1161/ 01.cir.0000437740.48606.d1.
11. Rydén L, Grant PJ, Anker SD et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with EASD. Eur Heart J 2013; 34(39): 3035– 3087. doi: 10.1177/ 1479164114525548.
12. Hanssen TA, Nordrehaug JE, Eide GE et al. Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention. Eur J Cardiovasc Prev Rehabil 2007; 14(3): 429– 437. doi: 10.1097/ HJR.0b013e32801da123.
13. Lachman S, Minneboo M, Snaterse M et al. Community-based comprehensive lifestyle programs in patients with coronary artery disease: Objectives, design and expected results of Randomized Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists. Am Heart J 2015; 170(2): 216– 222. doi: 10.1016/ j.ahj.2015.05.010.
14. Giannuzzi P, Temporelli PL, Marchioli R et al. Global secondary prevention strategies to limit event recurrence after myocardial infarctionresults of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168(20): 2194– 2204. doi: 10.1001/ archinte.168.20.2194.
15. Polsook R, Aungsuroch Y, Thongvichea T. The effect of self-efficacy enhancement program on medication adherence among post-acute myocardial infarction. Appl Nurs Res 2016; 32(1): 67– 72. doi: 10.1016/ j.apnr.2016.05.002.
16. Yan J, You LM, Liu BL et al. The effect of a telephone follow-up intervention on illness perception and lifestyle after myocardial infarction in china: A randomized controlled trial. Int J Nurs Stud 2014; 51(6): 844– 855. doi: 10.1016/ j.ijnurstu.2013.10.011.
17. Bellman C, Hambraeus K, Lindbäck J et al. Achievement of secondary preventive goals after acute myocardial infarction: A comparison between participants and nonparticipants in a routine patient education program in sweden. J Cardiovasc Nurs 2009; 24(5): 362– 368. doi: 10.1097/ JCN.0b013e3181a9bf72.
18. Hwang SY, Kim JS. Risk factor-tailored small group education for patients with first-time acute coronary syndrome. Asian Nurs Res 2015; 9(4): 291– 297. doi: 10.1016/ j.anr.2015.07.005.
19. Gallagher R, Roach K, Belshaw J et al. A pre-test post-test study of a brief educational intervention demonstrates improved knowledge of potential acute myocardial infarction symptoms and appropriate responses in cardiac rehabilitation patiens. Aust Crit Care 2013; 26(2): 49– 54. doi: 10.1016/ j.aucc.2012.01.002.
20. Kirchberger I, Hunger M, Stollenwerk B et al. Effects of a 3-year nurse-based case management in aged patients with acute myocardial infarction on rehospitalisation, mortality, risk factors, physical functioning and mental health. A secondary analysis of the randomized controlled KORINNA study. PLoS One 2015; 10(3): e0116693. doi: 10.1371/ journal.pone.0116693.
21. O’Brien F, McKee G, Mooney M et al. Improving knowledge, attitudes and beliefs about acute coronary syndrome through an individualized educational intervention: A randomized controlled trial. Patient Educ Couns 2014; 96(2): 179– 187. doi: 10.1016/ j.pec.2014.05.022.
22. Harbman P. The development and testing of a nurse practitioner secondary intervention for patients after acute myocardial infarction: a prospective kohort study. Int J Nurs Stud 2014; 51(12): 1542– 1556. doi: 10.1016/ j.ijnurstu.2014.04.004.
23. Jorstad HT, Alings AM, Liem AH et al. RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists. Neth Heart J 2009; 17(9): 322– 328.
24. Králíková E, Češka R, Pánková A et al. Doporučení pro léčbu závislosti na tabáku. Vnitř Lék 2015; 61 (Suppl 1): 3– 15.
25. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery dinase. Eur Heart J 2013; 34(38): 2949– 3003. doi: 10.1093/ eurheartj/ eht296.
26. Roffi M, Patrono C, Collet JP et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37(3): 267– 315. doi: 10.1093/ eurheartj/ ehv320.
27. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ ESC guidelines for the management of arterial hypertension. J Hypertens Manag 2013; 31(7): 1281– 1357. doi: 10.1097/ 01.hjh.0000431740.32696.cc.
28. Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569– 2619. doi: 10.1093/ eurheartj/ ehs215.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2017 Číslo 3
Najčítanejšie v tomto čísle
- Cardiovascular risk stratification and new serum lipid target levels
- SGLT2 inhibitors (gliflozins) antidiabetics, antihypertensives or drugs for heart failure?
- Statin intolerance – finding practical solutions
- Infective Endocarditis